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Patients with the autoimmune blistering disease 
pemphigus foliaceus (PF) have circulating autoanti-
bodi~s directed against the desmosomal cadherin 
desmoglein 1 (Dsgl). Based on the fact that purified 
IgG fractions from PF patients induce loss of cell 
adhesion in organ culture and in a ~eonatal mouse 
model, it has been proposed that these anti-Dsgl 
antibodies play ~ pathogenic rQle in blister forma-
tion. To directly address whether antibodies in PF 
sera specific for the Dsgl extracellular don'lain are 
ip.deed patqogenic in the disease, PFIg, a chimeric 
proteip containing the entire extracellular domain of 
human Dsgl and the constant J;egion ofhu~an IgGl, 
was produced by baculovirus e?Lpression. Incubation 
of PF p~tients' sera with the PFIg baculoprotein 
removed the immunoreactivity of autoantib~dies 
against keratinocyte cell surfaces in all 20 PF and 
eight Brazilian Pf patients' sera tested. This adsorp-
tion was conformation dependent, beca use PFlg pro-
tein denatured by 10'fV pH or heat was no longer able 
P emphigus is a li fe-threatening autoimmune blistering disease of skin and mucous m embranes [1- 4] that has , two m aj o r subtypes based o n c1inica.1 and histologic features, pemphigus vulgaris (PV) and pemphigus folia-ceus O)F) . C linically, PV is characterized by fl acc id 
blisters and wide-spread erosions of the skin and ora l mucosa, 
whereas PF is characterized by small flaccid blisters and scaly 
c rusted erythematou~ les ions of the skin. Histologically both sub-
type's exhibit intr~epidermal bJ.ister formation w ith loss of ke rati-
nocyte cell adhesion . However, in PV the spljt occurs just above 
the basa l cell layer, whereas in PF the split occurs in the upper part 
of the epidermis, at the level of the granular layer. In both PV, and 
PF, autoantibodies of the IgG iso type bind to affected epithe lja ;11 
11 ;110 in a characteristic intercellular staining patte rn and circulating 
autoan tibodies ar~ detected in the sera of patients [2,3 ] . Puri.fied 
IgG fro m patients with pemphig us can induce the loss of cell 
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to adsorb the imlnunoreactivity of PF sera. Further-
more, the incubation with the PFIg baculoprotein 
eliminated the pathogenic activity of PF patients' 
sera and prevented gross blister formation in a neo-
natal mouse model of pemphigu~. Anti-Dsg~ anti-
bodies eJuted fro'm the PFlg protein column were 
pathogenic as they resuJted in the appearance of 
gross blisters in peonatal mice with typical histolo-
gic findings of PF. These ol?servations indicate that 
the extracellular domain of Dsgl expressed b y bacu-
lovirus is capable of ~pecifically immunoadsorbing 
pathogenic au~oantibo4ies from' PF patients' sera and 
provide direct evidence tqat the anti-Dsgl auto-
~ntibodies in PF s~ra are ind~ed pathogenic. The 
avail~bility of tIlls Dsgl recombinant protein may fa-
cilitate the developme~t of antigen-specific p.lasn'l3-
pheresis as l' ~ovel therapeutic strategy in pemphi-
gus. Key words: desmogieill/baCliiovirlls expression/cadl,'erin/ 
autoimmune disease. ] IIIvest D efl!,atoi 104:895-901, 1995 
adhesion, with the sam e histology as that seen in patien ts, in skin-
o rgan culture [5,6] and in a neonatal m o use model [7]. Tmmu-
nochemical analyses of the antigens, targeted by PV and PF anti-
bodies, have demonstrated tha t they are 130-kO and 160-kD 
glycoproteins, respectively [8 - 13] . R ecen t cDNA cloning has 
revea led that these m o lecul es are both m embers of the desmoglein 
(Dsg) subfa mily of the cadherin supergene fami ly [14-18]. The PV 
and PF antigens are now termeq Dsg3 and Dsgl, respectively [19]. 
Brazilian PF (BPF) or fogo selvagem is an endemic form of PF 
fo und in hot humid wooded areas in central and western Brazil 
[20,21 ] , and exhibit~ the sam e autoantibody specificity agajnst Dsgl 
as PF [22]. 
To investigate the pathophysiology of pemphigus and to test the 
hypo th esis that autoantibodies directed against desmogl eins are 
di rectly responsible for blister fonnation , we first u tiljzed the 
cloned PV antigen cDN A to produce recombinant bacteria.lly 
expressed fusion proteins representing specific regions of the 
extracellular domain [23]. Using this approach we found th at IlP to 
60% of PV sera recognized epitopes in EC1, 2, and 4 domains as 
assessed by il11muno blotting of denatured protein. Autoan tibodies 
affinity purified from patient sera o n a column of a bacterially 
generated fusion protein containing ECl-2 bu t not EC3-5, resulted 
in histologically defin ed PV blisters when passively transferred to 
neonata l mice, suggesting that the ECl-2 subdol11ain contains at 
least one pathogenic epitope. Apparently, however, 1110st patllO-
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genic epitopes were not represented in the bacte riall y expressed 
proteins, as the pass-through fraction from the column retained the 
ability to cause gross blisters [23 ]. We hypothesized that tlus failure 
to completely adsorb the pathogenic antibodies from PV sera was 
due to the incomplete regeneration of conformational epitopes 
within the PV antigen . Such epitopes have been shown to be 
important in conferring inununogenicity to most native proteins 
[24,25]. 
To overcome this linutation of the bacterial expression system, 
we employed a baculovirus vector to produce PVlg, a secreted 
form of the PV antigen that is a chimeric molecule comprising the 
entire extracellular domain of Dsg3 fu sed with the con stant region 
of human IgGl [2 6]. This protein was expressed in eukaryotic cells 
where post-translational modification s including gly.cosylation and 
proteolytic cleavage al so occur. The resulting PVlg baculoprotein 
harvested from the condition ed m edium was able to adsorb immu-
noreactivity against keratinocyte cell surfaces in - 40% ofPV sera. 
Perhaps ~ore impor~antly, the PVlg protein was demonstrated to 
remove pathogenic autoantibodies from PV sera, preventing gross 
blister formation in neonatal mice. These findings are consistent 
with the possibility that the secretec\ PVlg molecules more accu-
rately refl ect the n ative conformation of the Dsg3 extracellular 
domain than do the bacterially expressed proteins. 
T h e purpose of the present study was to test directly whether 
antibodies specific for Dsgl are likewise' responsible for the char-
acteristic blisters seen in PF. Using a similar approach, we have 
engineered a secreted form of Dsgl containing the e ntire extracel-
lular domain fused with the con stant region of IgGl, and h ave 
expressed tlus protein usin g a baculovirns vector. The results 
reported h ere demonstrate for the first time that antibodies specif-
ically directed agaiJ15t the Dsgl extracellular domain are pathogenic 
in PF, and that, in contrast to the previous studies with PV, the PFlg 
protein 'removed immunoreactivity from 100% of PF sera tested. 
MATERJALS AND METHODS 
Human sera Sera from patients with c1irtically and histologicall y typica l 
PF, Brazilian PF (BPF), PV. and bullous pemphigoid (8P) exhibiting charac-
teristic imlTIul1o Auo resccncc staining on nOfl1131 i1lllnan cpidcnni s were used 
in tlus study. Two PF sera used in the neonatal mice study were obtained by 
plasmaphcresis (generous gifts from Dr. jolm R . Stanley at NIH and Dr. 
Koji Hashimoto at Osaka University). 
Construction of PFIg Expression Plasmid cDNA coding for the 
signal peptide and the prosequence as well as the entire extracellular domain 
of Dsgl was obtained by polymerase chain reaction (PCR) amplification on 
pKS-Dsgl containing the entire coding region for Dsg1 (GenBank accession 
number X56654) [16]. Oligonucleotides were designed with BglIl and Sail 
sites at the 5' and 3' ends, respectively, as well as the polyhedrin ilutia tion 
codon context (5'-CCTATAAAT-3') [27] immediately upstream of the 
ATG codon ofDsgl as follows: 5' primer, 5'-GAA-GAT-CTC-CTA-TAA-
ATA-TGG-ACT-GGA-GTT-TCT-TCA-GAG-3'; 3' primer, 5'-GTT-
GTC-GAC-ATG-TAC-ATT-GTC-TGA-TAA-CAA-ATC-3'. A baculo-
virus transfer vector containing the cDNA for the constant rcgion of human 
IgG1 was obtained by removal of sequence encoding the Dsg3 extrace llular 
domain from pEVmod-PVlg by digestion with BglII and Xho l [26]. T he 
Dsgl PCR product was digested with BglIl and SaIl and ligated togetilCr 
with the BgIIl-XhoI-cut pEVmod-PVlg. T lus construct was designated 
pEVmod-PFlg. 
Production ofPFIg by Baculovirus pEVmod-PFlg was cotransfected 
with the BaculoGold baculovirus DNA with a lethal deletion (Pharmillgen. 
San Diego, CAl into cultured insect Sf1) ce ll s and recombinant viruses 
contailung PFlg codi~g scquences wcre obtained, as previously reported 
[26]. Typically, approximately 3 X 106 Sf1) ce ll s iJl a 60-mm dish were 
transfected with a mixture of2 JLg ofthc pEVmod-PFlg plasmid DNA , 0.5 
JLg of the 8acuioGoid DNA, and 30 JLI of Lipofectin (GmCO BRL, 
Gaithersburg, MD) in scrum-free Grace's mcdium (GmCO lllU) . Recom-
binant viruses were collected from culture supernatant and high-titer virus 
stock was obtained after sevcral rou nds of reamplification. 
For production of PFlg. High Fivc cell s (Invitrogen, San Diego, CAl 
cultured in serum-free EX Cell 400 mcdium URH Biosciences. Lenexa, KS) 
wcre infected with high-titer virus stock, incubated at 27°C for 3-4 d, and 
stored at - 70°C after removing ce ll debris by centrifugation. O n averagc . 
the supernatant containcd 10-30 ILg/ ml of ti,e PFlg protein. as measured by 
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a protein assay kit (Bio Rad Laboratories, Richmond. CAl after purification 
with protein A-Sepharose (Pharmacia, Uppsala, Sweden). 
In the previous study [26], the PVlg baculoprotein in culture supernatant 
wit!lOut purification was used to incubate with PV sera . In tlus study we 
attempted to concentrate the baculoprotein with pro te in A to make a PFlg 
affiluty column . In initial experiments , the PFlg baculoprotein was eluted 
from the protein A in a low pH glycine buffer (pH 2.4). However, as the 
resulting protein lost its ability to adsorb PF immunorcactivity from sera, 
affinity co lumns were subsequently gcnerated using PFIg protein bound 
directly to protein A-Sepharose. To make a PFlg affiluty column. typically 
100 ml of culture supernatant contai'Ung the PFlg was incubated with 200 
JLI bed volume of protein A-Sepharose (binding capacity. - 20 mg of human 
IgG per 1 ml bed volume of protein A-Sepharose, Pharmacia) at 4°C 
overnight. Subsequently, protein A-binding capacity was saturated by 
incubation with an excess amount of normal human sera. and the col~mn 
was washed with Tris-buffered saline with 1 mM calcium (TBS-Ca) several 
times and stored at 4°C ' until use. Protein A-Sepharose incubated with 
culture supernatant of non-infected High Five cel ls followed by poqllal 
human sera was used as a control column. 
Irnmunoblot Analysis Purified PFlg with protein A-Sepharose was 
resuspended in sodium dodecylsulfate sample buffer (62.5 mM Tris-HCI, 
pH 7.5, 1°;', sodium dodecylsulfate, 0.0025% bromophenol bluc, 10% 
glycerol, with or without 2.5'% 2-mercaptoethanol). The PFIg protein was 
separated by sodium dodecylsulfate-polyacrylanude gel electrophoresis and 
transferred to a PVDF membrane (MiUiporc Corp ., Bedford, MA). To 
detect the PFlg molecule, the membrane was incubated with tllOusandfold-
diluted alklline-phosphatase-conjugated anti-human IgG antibodies 
(Zymed Laboratories, Inc., San Francisco, CAl. To examine reactivity of 
the PFlg molecule with patient sera. the membrane was incubated with 
fifty-fold diluted human scra (21 PF, 18 BPF, 26 PV, l OB I', and five normal 
sera), then thousandfold diluted mouse anti-human IgG4 antibody (Chemi-
con, Temecula , CAl, and visualized with thousandfold dilu ted alkaline-
phosphatase-conjugated goat anti-mousc IgG antibodies (Zymed Labora-
tories, Inc.). 
Immunoadsorption of PF Sera with PFlg Twenty microliters of 
patient sera were incubated with an - 5 JLI bed volume of PFlg protein 
A-Sepharose (containing - 50 ILg ofPFlg) or protein A-Sepharose saturated 
onl y with normal human sera (control column) at room temperature fo r 4 h 
or at 4°C overnight with gentle rotation. The treated sera werc then serially 
diluted up to 5120 times in TBS-Ca and subjected to indirect immunoAu-
o rcscencc staining on cryoscctioned normal hunlan skin. The inll11Ul1 osta in-
ing was visualized with fiftyfold diluted Auorescein isotluocyanate-conju-
gated anti-human IgG antibodies (Dako, Copenhagen, Denmark). 
For ti,e neonata] micc study, 10 ml ofPF scra were applied to eitl1Cr the 
PFlg-protein A column (- 0.5 ml bed volume containing - 5 mg of the PFlg 
protein) or the control column at 4°C overnight by continuous circulation 
and IgG was prepared from pass-through sera by precipitation with 40% 
ammonium sul fate . dialyzed against phosphate-buffered sa line with 0.5 mM 
cakium (PBS-Ca), and concentrated with a micro concentrator, Centriprep 
100 (Amicon, Beverly, MA) to t ml (1/10 volume of original serum 
volume) . One h~ndred to one hundred fifty microliters ofc,oncentrated IgG 
was injccted subcutancously into neonatal BALBlc mice «24 h of age) as 
described previously [23.26]. Neonatal mice were examined and biopsied 
18 h after injection. ' 
Antibodies bound to the PFlg-protcin A column and the control column 
used in the above experiment were elutcd with an elution bufFer (number 
21009. Pierce. R ockford, IL) and immediately neutrali zed with one fifth 
volume of 2 M Tris-HCI, pH 7.4, dialyzed against PBS-Ca, and conCCn-
trated with Cel1triprcp 100. Approximately one milli]itcr of IgG so lution 
was obta ined fro m the column incubated with 10 ml of PF sera . One 
hundred to one hundred fifty micro liters of concentrated IgG was injedeQ 
in to neonatal mice to examine pathogcnic activity of the eluted PF IgG . 
RESULTS 
Production of a Secreted ForlTl of Dsgl, PFlg, by Baculo-
virus Expression A cDNA en coding the sig nal peptide, the 
prosequence, and the entire extracellular domain of Dsgl was 
ligated in frame with a cD NA en coding the constant region of 
human IgG l in a baculovirus transfer vector, pEVmod (Fig 1). 
Expression of th.is vector in insect High Five cells resulted in the 
production of a secreted chimeric PFIg protein whose con centra-
tion in the culture supernatant was 10 to 30 fLg/ml . The presence 
of the IgG constant region facilitated the identification of this 
molecule with anti-human IgG antibodies and purification on a 
prote in A column. Under re ducing conditions PFIg was detected as 
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Figure 1. Molecular structure of a secreted forlTl of Dsgl chitneric 
lTlolecule, PFlg. The region derived from the extracellular domain of 
Dsg1 contains the signa l peptide (S) , the prosequence (P). and the extra-
cellular domains (ECl to EC5). The region derived from the constant 
region of human IgGl includes hinge (H). CH2, and C H3 domains. To fuse 
the t\VO proteins in fraJTIc, one va.1ine was introduced. 
a doublet of a major 112-kD and a minor 115-kD band by inU11Uno-
blot analysis (Fig 2, lalle 1). T he higher-molecular-weight band is 
considered to represent the lUlprocessed molecule, as similarly ex-
pressed, unprocessed fonns of the chimeric PVlg [26] and E-cadherin 
molecules [28] have also been observed in insect culture medium. 
Appeara.nce of these fOl1l1S is likely due to saturation of the proteolytic 
processing machinery in the insect cell cultures secreting high levels of 
ectopically expressed protein. Under nonreducing conditions, PFlg 
appeal'ed as a prominent 217-kD band (Fig 2, lalle 2), suggesting it is 
secreted as a homodimer, presumably linked through disulfide bonds 
in the hinge region. The PFIg molecule also appeared to be glycosy-
lated in High-Five cells, as tunjcamycin treatment reduced its molec-
ular weight to - 102 kD (M. Amagaj, unpublished result). 
Immunoblot Analysis of the PFlg Baculoprotein T he PFIg 
molecule was subjected to immunoblot analysis with PF, EPF, PV, 
EP, and normal control sera. T he PFIg was recognized by 10 of 21 
PF sera (48%), 10 of 18 EPF sera (56%), and four of 26 PV sera 
(15%), but not by any of 10 EP or five normal control sera 
(representative data shown in Fig 3). Dsg1 is known to be detected 
only by about one th ird of PF sera by immunoblot analysis using 
normal human epidermal extracts or bovine muzzle desmosomaJ 
preparation as a substrate [9,1 2,22,29,30], even though Dsg1 is 
recognized by all PF sera by immunoprecipitation [31], suggesting 
that many of the Dsg1 epitopes are destroyed during the sodium 
dodecylsulfate-po lyacry lamide gel e lectrophoresis procedure. 
About two thirds of PV sera also con tain antibodies agajnst 
2 
Figure 2. Production of the PFlg molecule by baculovirus expres-
sion. The PFlg was pU"ified fro m culture supernatant with protein 
A-Sepha rose, separated on sodium dodecylsul f.,te-po lyacrylamide gel elec-
trop horesis either in reducing and nonreducing condition, transferred to a 
PVDF membrane. and visua li zed with allti-human IgG antibodies. T he PFlg 
was detected as a doublet (all'OwJ,cnds) of a major 11 2-kD and a minor 
115-kD band in reducing condition (1(lIIe 1) and as a prominent 217-kD 
band in nonreducing condition (lnll e 2) . B(II'S on the right indicate molecular 
weight standards of 200, lt6, and 97 kD. from top to bottom. 
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Figure 3. hnnlunoblot analysis of the PFlg with PF, BPF, PV, and 
norlTlal control sera. Blotted PEg was incubated sequentially with human 
sera [PF, BPF, PV. and normal (N) sera] . anti-human IgG4 mouse mono-
clonal antibody, and alkaline phosphatase-conjugated anti-mouse IgG 
antibodies. An alTowllCnd indicates the location of the PFlg baculoprotein . 
Dsgl, as previously determined by immunoprecipitatjon or 
immunoblotting [11,12,32]. Therefore, the results of the immu-
noblot analyses with the PFIg baculoprotein are consistent with 
the previous observations and suggest that the PFIg represents 
equiva lent epitopes of the native Dsgl. 
Adsorption of Pathogenic Autoantibodies from PF Sera by 
the PFIg Baculoprotein We next wanted to determine 
whether the PFIg protein is capable of adsorbing heterogeneous 
antoantibodies against Dsg1 from PF patients ' sera. Twenty micro-
liters of 20 PF sera or e ight EPF sera were incubated with - 50 /Lg 
of the PFIg bound to protein A-Sepharose or the control protein 
A- Sepharose and the immunofluorescence titers were examined on 
cryo-sectioned normal human epidemlis (Table I). The immwlO-
reactivity against keratinocyte cell surfaces of all the PF and EPF 
sera tested was completely removed after incubation with the PFIg 
baculoprotein (Fig 4 and Table I). The titers ofPV sera were not 
reduced by incubation with the PFIg baculoprotein . Denaturation 
of the PFlg protein by low pH or heat abrogated its ability to 
remove immunoreactivity from PF sera, suggesting the possibility 
that these epitopes are conformationally sensitive. 
To determine whether the PFIg protein is able to remove 
pathogenjc activity from PF sera, two PF sera obtained by plasma-
pheresis, w hose indirect immunofluorescence titers were as high as 
5120 on normal human skin (Table I), were applied to a PFIg 
protein A-Sepharose column or a control column without the PFIg 
baculoprotein. IgG was then prepared from flow-through fractions 
by 40% ammonium precipitation, concentrated, a.nd injected in 
Table I. Removal of Immunoreactivity of PF Sera by the 
PFlg BaculoproteinO 
Number of Scra 
PF se ra (tota l 20 sera) 
5 
2 
6 
3 
2 
BPF se ra (total 8 sera) 
1 
3 
3 
PV sera (total 3 sera) 
1 
Titers After 
Adsorption with 
Control 
5120 
2560 
1280 
640 
320 
160 
80 
1280 
640 
320 
160 
1280 
640 
320 
PFlg 
1280 
640 
320 
. 1 Twenty PF sera . e ight BPF. or three PV sera were incubated with the PFlg column 
or the contro l cailium and their immul1oAuorcsccncc titers on nonnal human skin were 
measured . 
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Figure 4. Adsorption of PF autoantibodies by incubation with the PFlg baculoprotein. PF scra (PF 1, A and B; PF 2, C and D) wcrt! incubated 
either with the PFlg protein A-Sepharose (B and 0) or with the control Sepharose (A and C), seriall y diluted in TBS-Ca, and applied to immuno Au orescence 
staining of normal human skin . Th.e fi gures arc shown at 1 :40 dilution. T hc immunoreactivity o f PF se ra against kcra tinocytc ce ll surfaces was completely 
removed by the incubation with the PFl g. Bnr, 100 jLm. 
neonata l mice (Fig 5, Table II). IgG passed through the contro l 
column resulted in extensive blisters and erosion s in neonatal mice 
w ith loss of cell adhesion of keratinocyles in the granular layer, a 
typ ica l histologic finding of PF (Fig 5A,B) . D irect immunofluores-
cence of mo use skin was positive for hum an IgG (Fig 5D) and 
indirect immunofluorescence titers in these mi ce were 160 to 640. 
In contrast, IgG passed through the PFlg co lumn did not cause any 
blister o r erosio n ; fuf'thermore, hi stologic anal ys is of the skin 
revealed no sign of blister fo rmation (Fig 5A,C). ln addition , there 
was no apparcnt deposition of hum an IgG in the epidermi s (Fig 
5E), nor was there detectabl e circul ating human IgG in the 
peri pheral blood of these mi ce . T hese findings indi ca te that the 
PFlg baculoprotein is capable of etiminating the pathogenic activity 
of PF sera that leads to a loss of keratinocyte cell adhesion. 
Anti-Dsgl IgG in PF Sera Is Pathogenic To determine 
w hether the ,lIltibodies that remained bo und to the PFlg baculo-
protein were pathogenic, the antibodies were e lu ted from the 
PFlg-protein A column or the contro l column, concentrated, alid 
injected into neonatal mice. T he antibodi es eluted from the PFl g 
column resulted in the formation o f gross blisters in neonatal mice 
w ith typ ical histologi c findings of PF (Fig 6A,B, Table III). 
Deposition of IgG was detected on ke ratin ocyte cell surfaces and 
circula tin g hum an IgG titers were 320 to 640 in these mice. In 
con trast, the eluted antibodies fro m the contro l column did not 
cause an y change in the epidermis, deposition of human IgG in the 
skin , or detectabl e circulatin g human IgG in the mice sera (Fig 
6A,e, Table III). 
Taken together, these observa tions demonstrate tha t the PFlg 
bac uloprotein specifically removes the pathogenic autoantibodies 
fi'om PF sera as de tected by both immuno fluore scence ana lys is and 
;11 1/ ;1/ 0 neonatal mo use assay. Furthermore, these results provide the 
first direct evidence that the anti-Dsgl IgG in PF sera lead to 
acantholysis and blister formation in PF. 
DISCUSSION 
The goal of the present study was to produce a recombinant form 
of Dsgl that wou ld allow us to tes t directly the importance of this 
molecule in th e pathophysiology of PF, by prov iding a means of 
relllo v ing pathogenic autoan tibodies fi'om PF sera by affinity chro-
matog raphy. As our previous studies suggested that bacterially 
expressed domains were no t recogni zed by m ost PV autoantibodies 
[23] , w e chose to express a secreted form of the PF extracellul ar 
dom ain fused with th e constant regio n of human IgGl in baculo-
virus . We predi cted that the resu lting mol ecule wou ld re tain 
enoug h of the native conformation th at it would act as a more 
efficie nt immunoadsorption m atrix for auto immune sera. Indeed, 
incubation of PF and BPF sera w ith tlu s PFl g protein not only 
rellloved iml11un oreactivity against keratinocyte cell surfaces of 
norl11 a l human epidermis ;11 II;lro, it al so abrogated the abili ty o f 
these sera to cause blister formation in neonatal mice. Furthermore, 
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Figure 5. Elitnination of pathog enic activity ofPF sera by the incubation with the PFlg. PF sera were incubated either with t he PFIg column or 
the contro l co lumn , the n IgG w as prepared. concen trated, and injected into n l!onatal mice. Mice inj ected with IgG passed over the control column 
demo nstra ted extensi ve blisters and e rosio ns (A, Il!ft two micl!) and showed intraepidermal bli ster formation at the level o f the granular layer (8) and human 
IgG deposition on keratinocyte cell surfi,ccs of the mo use epidermis (D) . In contrast, mice injected with IgG passed over the PFlg column showed in tact slcin 
(A , tw o ri ght Illi ce), no sign of bli ster fo rma tio n (C), and no apparen t human IgG depositio n (E) . Bnrs, 5 ml11 in A, 100 J.L1ll in B-E. 
aftini ty-purified antibodies that bound to the PFl g protein w ere 
subsequ entl y sho wn to cause a loss o f ce ll adhesio n and blister 
form ation in mice. T hese resul ts provide the first direct demonstra-
tion tha t anti-Dsgl an tibodies are the causa tive agen t in PF. 
Together with prev io us wo rk [26], these data demo ns tra te that 
both PV and PF arc anti-cadhcrin autoimmune diseases , and 
support the idea that the desm ogleins play a critical role in 
desmosomal- m ediated adh esion. H owever, the precise m olecular 
mechanism by which antibody binding to keratinocyte cell surfaces 
leads to blister fo rmation has yet to be detenllined . It might be a 
direct inh.ibito ry effect of antibody binding on cell-cell in teractions 
or the specific induction o f do wnstream signals resul ting from 
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Table II. Elitnination of Pathogenic Activity of PF Sera 
by Incubation with the PFlg Baculoprotein" 
Number of Mice 
IgG Injected Injectcd Blistered DIF" IIF' 
IgG of PF serum 1 trea tcd with 
Control column 10 10 + 320-640 
PFlg column 8 0 
IgG of PF scrum 2 treated with 
Control column 8 8 + 160-320 
PFlg column 7 0 
a IgGs prepared from a flow-through fraction of the PFIg column or the control 
column were injected into neonatal mice to de termine the ir pathogcnjc activity. 
b Human IgG deposition in the mouse skin was examined by direct immunofluo-
rescence. 
r C irculating human IgG titer in the Illice was determined by indirect immunoflu-
orescence using human skin as a substrate. 
antibody binding that promote acantholysis or inhibit desmosome 
assembly. Previously, plasminogen activator activity was reported 
to be stimulated by pemphigus autoantibodies [6], suggesting that 
proteolytic digestion of other celJ adhesion molecul es of keratino-
cytes might be involved in augmentation of blister formation. 
Other possible downstream signals, including regulation of desmo-
some assembly and disassembly by phosphorylation, should be 
explored in the future. 
The PFlg chimera used in this study contains the entire extra-
cellular domain ofDsgl but lacks the cytoplasmic domain. Thus the 
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Table III. Pathogenic Activity of Eluted IgG from PFlg 
Protein A Column" 
Number of Mice 
IgG Injectcd Injected Blistered DIF" II F' 
IgG c luted from 
PFlg colul11n 3 3 + 320-640 
IgG e luted frol11 
control column 3 0 
II IgGs affinity purified all the PFlg colullln or the control column we re injected into 
neonatal mice to dctcrmjne th eir pathogenic activity. 
'I, t. Sa m e as Table II. 
extracellular domain is apparently sufficient to remove not only all 
immunoreactivity against normal human epidermis from PF and 
BPF sera, but also all pathogenicity. Initially, tlus was somewhat 
puzzling, as we previously reported that some PF sera reacted with 
a bacterial fusion protein expressing the cytoplasmic doma in of 
bovine Dsgl as assessed by immunoblotting [33] . Although the 
underlying basis for tlus discrepancy is unclear, it is possible that 
IgG directed against the cytoplasm ic domain reacted only with 
tin ear epitopes that are exposed after denaturation during sodium 
dodecylsu lfate-polyacrylamide gel e lectrophoresis or possibly that 
the IgG recognized bovine-specific epitopcs. Based on our current 
results, we hypothesize that pathogenic autoantibodies against 
native Dsgl may be generated excl usively against the extracellular 
portion of the molecule in PF patients, and that autoantibodies 
Figure 6. Autoantibodies immunoaffinity purified on the PFlg reprcsent the pathogcnie componcnt in PF sera. The autoantibodies bound to 
the PFlg column or thc control column werc elu ted, conccntrated, and injccted into neonatal mjce. Antibodies eluted [rom the PFlg column led to gross 
blister formation and erosion in mice (A, a top mouse) w ith typica l histologic findings ofPF (B). However, the antibodies eluted fro m the contro l colul11n 
did not show any sjgn of causin g blister format io n (A, a bottom mouse, and C). BM, 5 mm in A, 100 JLm in Band C. 
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against the cytoplasmic domain arise secondarily to the pathogenic 
antibodies . In a study in which PV autoantibodies were removed 
using a simiJar approach, approximately 60% of the PV sera retained 
immunoreactivity with epidermis even though the titers were 
significantly reduced [26]. However, when these PV sera were 
incubated with a mixture of PVlg and PFIg baculoproteins , both 
containing only the extracellul ar do main of the respective desl110-
g lein mol ecules, the immunoreactivity was completely abolished 
(M. Amagai, unpublished results). This result indicates that the 
remaining immunoreactiv ity in the initial experiments did not 
re fl ect the presence of autoantibodies diJ'ected against the cytoplas-
mic domain of e ithe r molecul e . an observation consi stent with o ur 
hypothesis stated above . 
In the present study, anti-Dsg1 antibodies eluted from the PFIg 
column ca used gross blisters in neonata l mice equivaJent to that 
resulting £i'om injectio n of whole IgG prepared by ammonium 
sulfate precipitation. T his result is in contrast to our previous 
o bservatio n that anti-Dsg3 affinity-purified on a column of b acte-
rially expressed fu sion prote in resulted in the formation of only 
mi croscopic blisters [23]. It is unlike ly that this reflects a quantita-
tive diffe rence iJl the amount of inj ected IgG, as affinity-purified 
IgG from as much as 50 m1 of PV sera was insufficient to induce t he 
fo rmatio n of gross blisters, whereas who le IgG from - 1 1111 of sera 
was sufficient. A long with our observations reported above regard-
ing denaturation of the PFIg bacu]oprotein. this result again suggests 
that impo rtaJlt conformationally sensitive epitopes required for recog-
nitio n by aJlti-Dsgl autoantibodies are not conserved in the bacterial 
protein, but are retained in the baculoprotein. 
In addition to revealing important clues regarding the pathogenic 
basis of pemphigus, the PFlg molecule reported here may be useful 
in designing a rapid diagnostic tool and a targeted therapy for 
pemphigus. Enzym e-linked immunosorbent assay using the PFlg 
protein as an antigen source would be sen sitive and speciftc, 
beca use IgG titers against onJy the pathogenic extracellul ar domain 
of Dsgl can be m easured. C urren tly, con ventional treatments for 
pemphig us employ the widespread administration of corticosteroids 
or immunosuppressive agents such as cyclophosphamide, m etho-
trexate, o r azathiopt;ne, in addition to plasmapheresis [4] . GlobaJ 
immunosuppression is often an unfortunate side effect of s u ch 
treatments, which are directed aga inst autoimmune diseases in 
general and are not specificaUy targeted against pemphigus. We 
have de m o nstrated that it is possible to specifically immunoadsorb 
pathogenic autoantibodies u sing recombinant proteins expressed by 
baculoviru s in PV [26] and PF (this study) . Similar affinity colU]11ns 
might be developed as a therapeutic immunoadso rption device to 
remove circ ulating pathogenic autoantibodies from patient plasma 
and retul'll all other no rmal antibodies and plasma components to 
the patient. Such a n ovel therape utic could also be applied to other 
autoimmune diseases, whose aut03ntigens have been cloned ::tnd 
whose recombin ant proteins are available. 
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